InsuFend

What the vendor page documents

InsuFend is a capsule marketed for blood-sugar balance, weight management and "regenerative potential". The page opens with a question aimed at people with diabetes — "are you pricking your fingers five times a day? Dealing with countless medications and injections?" — and answers that "they will all be a thing of the past".

Eight ingredients are named: gymnema sylvestris, cinnamon bark, eleuthero root, green tea, theobromine, chromium, vitamin B1 and vitamin D. No milligram amount is published for any of them, so the dose is unknown. The page says the formula is natural, non-GMO, stimulant-free, non-habit forming and made from plant ingredients.

Pricing is one bottle at $69 plus $9.99 shipping, three bottles at $59 each ($177) and six bottles at $49 each ($294), with free shipping on the larger packs and two bonus e-books. The vendor states a 60-day, no-questions-asked money-back guarantee and a one-time purchase. The page says satisfaction is "based on hundreds of reviews" without a numeric rating or individual review count.

What the page claims — and what it does not prove

The central promise is that InsuFend "helps naturally awaken the feedback loop responsible for the blood sugar and healing and regenerative potential that's lying dormant within you". That is not a recognised mechanism. Blood glucose is regulated by insulin, glucagon, the liver, muscle and fat tissue — not by a dormant "feedback loop" waiting to be switched on.

The page goes further with the idea that finger-pricking, medications and injections will become "a thing of the past". For type 1 diabetes, insulin is not optional; for type 2, many people need medication alongside diet and activity. A supplement page that suggests otherwise is making a dangerous claim, even if the wording is framed as a question.

The testimonials describe A1C falls and better fasting glucose. Those are meaningful outcomes, but they are self-reported, unverified and published by the seller. There is no product trial, no dose and no control group. We record the "medications will be a thing of the past" framing, the dormant-loop story and the missing doses as red flags.

A fair trial of a glucose supplement would run for at least three months, measure HbA1c against placebo, and report the change in medication use. InsuFend publishes none of that — and the one number that matters most in diabetes care, HbA1c, appears only in customer stories.

What the ingredients are studied for

• Gymnema sylvestre is a traditional herb with small trials suggesting modest glucose lowering. It can add to the effect of diabetes medication.
• Cinnamon bark has mixed small trials on fasting glucose and HbA1c. Effects are modest and product-dependent.
• Chromium is a trace mineral involved in insulin action; trials in people with diabetes have been inconsistent.
• Green tea provides caffeine and catechins. The page says it "blocks cellular glucose uptake", which is not an established effect of drinking or supplementing green tea.
• Eleuthero (Siberian ginseng) is an adaptogen studied for fatigue; glucose evidence is limited.
• Theobromine is a cocoa alkaloid with mild stimulant and vasodilator effects. It is not a diabetes treatment.
• Vitamin B1 (thiamine) matters for nerve health, and deficiency is more common in diabetes; correcting a deficiency is useful, but it is not glucose control.
• Vitamin D is important for bone and immune health; deficiency is common, but supplementation does not treat diabetes.

The honest summary: several ingredients with modest metabolic evidence, in unknown amounts, wrapped in a story that overstates what they can do.

Safety and who should be cautious

• Never stop insulin or diabetes medication because of a supplement page. Doing so can cause dangerous hyperglycaemia.
• Hypoglycaemia risk: gymnema, cinnamon and chromium can lower glucose. If you use insulin or sulfonylureas, monitor and ask your clinician before adding them.
• Kidney disease: some herbs and high-dose vitamins need dose adjustment.
• Surgery: disclose all supplements to your anaesthetist; glucose control matters.
• Pregnancy and breastfeeding: ask a professional.
• Diagnosis matters: type 1, type 2 and gestational diabetes are managed differently. A supplement does not change which one you have.
• Vitamin D and B1: useful if deficient, but test rather than guess.

Who it may suit — and who it does not

InsuFend may suit an adult with type 2 diabetes who has discussed supplements with their clinician and wants a short trial alongside prescribed care and monitoring. It is a poor fit for anyone with type 1 diabetes, anyone on insulin or sulfonylureas without glucose monitoring, anyone considering reducing medication, and anyone who wants a disclosed dose before buying.

Our diabetes category lists what we track, including GlucoTrust, SugarMute and GlucoTrust Bites. The comparison tool only pairs products in the same category, and our blood sugar guide explains which claims are worth checking. The methodology page shows how missing doses affect the score.

What to check before buying

1. Ask for milligram amounts for all eight ingredients; the page publishes none.
2. Keep your monitoring routine — do not stop finger-pricks on the strength of a sales page.
3. Confirm the 60-day terms and who pays return shipping.
4. Tell your doctor before adding any supplement to diabetes medication.

How the score treats this product

The score rewards the documented 60-day guarantee, the one-time purchase, the eight named ingredients and the capture date. It does not award evidence points for unpublished doses or the absent trial, and it records the "medications will be a thing of the past" framing and the dormant-loop story as red flags. The "hundreds of reviews" claim is shown as a vendor statement and excluded from the score. The result reflects disclosure and commercial terms, not a medical judgment.

Sources

• InsuFend official page (captured 2026-11-08)
• NIDDK — Type 2 Diabetes
• MedlinePlus — Gymnema
• MedlinePlus — Chromium
• ADA — Dietary Supplements

Editorial content by the ViaReviews Research Team, last reviewed 2026-11-08. Informational only, not medical advice.